The chimeric protein SA-4–1BBL alone also protected mice against tumor challenge in various preclinical mouse models via non-specific activation of CD4+ T and natural killer cells demonstrating its ability to prime the immune system for cancer prevention [98]. This evidence concerns the gene CD4 and cancer.